Home' Australian Pharmacist : Australian Pharmacist September 2012 Contents 724 Australian Pharmacist September 2012 I ©Pharmaceutical Society of Australia Ltd.
COUNSELLING IN PRACTICE
Take home message
Anxiety disorders are a common cause
of morbidity. They commonly arise
in childhood or adolescence and can
have significant adverse effects on a
person’s development and quality of
There is good evidence that they are
able to be treated effectively with
psychological therapies such as CBT,
with severe or unresponsive symptoms
sometimes requiring additional
pharmacotherapy including SSRIs.
1. Which of the following statements is
a) Symptoms of anxiety may worsen
upon starting medication to treat
b) Up to 10% of all people experience an
anxiety disorder at some time in their
c) Anxiety disorders which appear in
adolescence tend to be self-limiting.
d) SSRIs are the first line for long-term
therapy of anxiety disorders in adults.
a) helps people with anxiety disorders to
understand the causes of their physical
b) is the most effective psychological
therapy for reducing the symptoms of
c) helps people with anxiety disorders to
understand the impact of their early
lives on their symptoms.
d) is not effective for reducing
the symptoms of depression in
3. The most appropriate
pharmacotherapy for a 16-year-old
with OCD is:
4. Which of the following statements is
a) Exercise is more effective for reducing
symptoms of GAD than for symptoms
b) Meditation is a highly effective
treatment for anxiety disorders and
is associated with very few, if any,
c) CBT, stimulus control and sleep
restriction may all be effective for
Where can I get more information?
• Beyond Blue: www.beyondblue.org.au/
index.aspx 1300 22 4636
• Headspace – National Youth Mental
Health Foundation: www.headspace.org.
• Lifeline Australia: 13 11 14
• Kids Helpline: 1800 55 1800
• Black Dog Institute: www.
• SANE: www.sane.org 1800 18 SANE (7263)
• ReachOut.com: http://au.reachout.com
You discuss your concerns with Leah that
Caitlin may be exhibiting symptoms of
an anxiety disorder which is common at
her age and when undergoing significant
stress. You recommend that it is important
that her symptoms are discussed with her
doctor so that, if necessary, psychological
or pharmacological treatment can begin as
soon as possible to minimise the negative
effects of her symptoms on her schooling
and general wellbeing.
*Selection based on those that appear in
Reference number 3 and/or have a TGA
approved indication or PBS listing for anxiety
GAD – Generalised Anxiety Disorder
MDD – Major Depressive Disorder
OCD – Obsessive-Compulsive Disorder
PTSD – Post-Traumatic Stress Disorder,
SAD – Social Anxiety Disorder
1. Hunot V, Churchill R, Teixeira V, at al. Psychological therapies
for generalised anxiety disorder. Cochrane Database of
Systematic Reviews 2007, Issue 1. Art. No.: CD001848. DOI:
2. Reavley NJ, Allen NB, Jorm AF, et al. A guide to what works for
anxiety disorders. beyondblue: Melbourne; 2010.
3. Anxiety and associated disorders. In: eTG complete. Melbourne:
Therapeutic Guidelines; 2008. At: http://etg.hcn.net.au/
4. American Psychiatric Association. DSM-5 Development:
Anxiety Disorders. At: www.dsm5.org/ProposedRevision/
5. NPS Better Choices Better Health. Prescribing Practice Review :
PPR 48 Nov 09 – Anxiety disorders: Providing best care for
anxiety disorders in general practice. At: www.nps.org.au/
6. NPS Better Choices Better Health. NPS News: 65 Oct 09 –
Which treatment for what anxiety disorder? At: www.nps.org.
7. Ipser JC, Stein DJ, Hawkridge S, et al. Pharmacotherapy for
anxiety disorders in children and adolescents. Cochrane
Database of Systematic Reviews 2009, Issue 3. Art. No.:
CD005170. DOI: 10.1002/14651858.CD005170.pub2.
8. Beyond Blue. Anxiety. At: www.beyondblue.org.au/index.
9. Anxiety disorders. In: Rossi S (ed). Australian Medicines
Handbook. At: http://amh.hcn.com.au/view.
10. Anxiety disorders in childhood and adolescence. In: eTG
complete. Melbourne: Therapeutic Guidelines; 2008. At: http://
11. Cognitive behavioural therapy. In: eTG complete. Melbourne:
Therapeutic Guidelines Limited; 2008. At: http://etg.hcn.net.au/
12. Kapczinski FFK, Silva de Lima M, dos Santos Souza JJSS, et al.
Antidepressants for generalized anxiety disorder. Cochrane
Database of Systematic Reviews 2003, Issue 2. Art. No.:
CD003592. DOI: 10.1002/14651858.CD003592.
13. Australian Government Department of Health and Ageing.
Pharmaceutical Benefits Scheme. At: www.pbs.gov.au/pbs/
14. Insomnia. In: eTG complete. Melbourne: Therapeutic
Guidelines Limited; 2008. At: http://etg.hcn.net.au/
15. Krisanaprakornkit T, SrirajW, Piyavhatkul N, et al. Meditation
therapy for anxiety disorders. Cochrane Database of
Systematic Reviews 2006, Issue 1. Art. No.: CD004998. DOI:
16. Manzoni GM, Pagnini F, Castelnuovo G, et al. Relaxation training
for anxiety: a ten-years systematic review with meta-analysis.
BMC Psychiatry 2008 Jun 2;8:41.
17. Australian Government Department of Health and Ageing.
Australian Register of Therapeutic Goods. At: www.ebs.tga.
Links Archive Australian Pharmacist October 2012 Australian Pharmacist August 2012 Navigation Previous Page Next Page